RecruitingNCT07402577

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study


Sponsor

Roswell Park Cancer Institute

Enrollment

40 participants

Start Date

Mar 30, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study generates information on the feasibility and acceptability of a 3-month ecological momentary assessment (EMA) protocol to assess chronic pain and opioid use in adolescent and young adult (AYA) sarcoma survivors.


Eligibility

Min Age: 12 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is trying to understand why some young cancer survivors experience chronic pain after being treated for sarcoma (bone or soft tissue cancer), and how opioid pain medications affect them. It is a pilot study focused on teens and young adults. **You may be eligible if...** - You were diagnosed with sarcoma between ages 12 and 24 - You are currently under 70 years old and enrolled in survivorship care - Your cancer is currently showing no signs of active disease - You have meaningful ongoing pain (rated 3 or higher on a 0–10 scale) related to your cancer or treatment - You have a smartphone with internet access **You may NOT be eligible if...** - You are currently receiving active cancer treatment - You are unable to read or speak English fluently - You cannot complete assessments on your phone over a 3-month period Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon Intervention Study

Non intervention study


Locations(1)

Roswell Park Comprehensive Cancer Center

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07402577


Related Trials